Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

Defective Phagocytic Corpse Processing Results in Neurodegeneration and Can Be Rescued by TORC1 Activation.

Etchegaray JI, Elguero EJ, Tran JA, Sinatra V, Feany MB, McCall K.

J Neurosci. 2016 Mar 16;36(11):3170-83. doi: 10.1523/JNEUROSCI.1912-15.2016.

2.

An In Vivo Pharmacological Screen Identifies Cholinergic Signaling as a Therapeutic Target in Glial-Based Nervous System Disease.

Wang L, Hagemann TL, Messing A, Feany MB.

J Neurosci. 2016 Feb 3;36(5):1445-55. doi: 10.1523/JNEUROSCI.0256-15.2016.

3.

Lamin Dysfunction Mediates Neurodegeneration in Tauopathies.

Frost B, Bardai FH, Feany MB.

Curr Biol. 2016 Jan 11;26(1):129-36. doi: 10.1016/j.cub.2015.11.039. Epub 2015 Dec 24.

4.

Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.

Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ, Crary JF, Duyckaerts C, Ghetti B, Halliday GM, Ironside JW, Love S, Mackenzie IR, Munoz DG, Murray ME, Nelson PT, Takahashi H, Trojanowski JQ, Ansorge O, Arzberger T, Baborie A, Beach TG, Bieniek KF, Bigio EH, Bodi I, Dugger BN, Feany M, Gelpi E, Gentleman SM, Giaccone G, Hatanpaa KJ, Heale R, Hof PR, Hofer M, Hortobágyi T, Jellinger K, Jicha GA, Ince P, Kofler J, Kövari E, Kril JJ, Mann DM, Matej R, McKee AC, McLean C, Milenkovic I, Montine TJ, Murayama S, Lee EB, Rahimi J, Rodriguez RD, Rozemüller A, Schneider JA, Schultz C, Seeley W, Seilhean D, Smith C, Tagliavini F, Takao M, Thal DR, Toledo JB, Tolnay M, Troncoso JC, Vinters HV, Weis S, Wharton SB, White CL 3rd, Wisniewski T, Woulfe JM, Yamada M, Dickson DW.

Acta Neuropathol. 2016 Jan;131(1):87-102. doi: 10.1007/s00401-015-1509-x. Epub 2015 Dec 10. Review.

5.

Nitric oxide mediates glial-induced neurodegeneration in Alexander disease.

Wang L, Hagemann TL, Kalwa H, Michel T, Messing A, Feany MB.

Nat Commun. 2015 Nov 26;6:8966. doi: 10.1038/ncomms9966.

6.

p53 prevents neurodegeneration by regulating synaptic genes.

Merlo P, Frost B, Peng S, Yang YJ, Park PJ, Feany M.

Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):18055-60. doi: 10.1073/pnas.1419083111. Epub 2014 Dec 1.

7.

Connecting the dots between tau dysfunction and neurodegeneration.

Frost B, Götz J, Feany MB.

Trends Cell Biol. 2015 Jan;25(1):46-53. doi: 10.1016/j.tcb.2014.07.005. Epub 2014 Aug 26. Review.

8.

Glia are critical for the neuropathology of complex I deficiency in Drosophila.

Hegde VR, Vogel R, Feany MB.

Hum Mol Genet. 2014 Sep 1;23(17):4686-92. doi: 10.1093/hmg/ddu188. Epub 2014 Apr 23.

9.

Tau promotes neurodegeneration through global chromatin relaxation.

Frost B, Hemberg M, Lewis J, Feany MB.

Nat Neurosci. 2014 Mar;17(3):357-66. doi: 10.1038/nn.3639. Epub 2014 Jan 26.

10.

Genetic influences and neuropathological sequelae of repetitive brain injury. Reply.

Mannix R, Meehan WP, Feany M, Grant PE, Mandeville J, Kaplan DL, Whalen M.

Ann Neurol. 2014 Apr;75(4):618. doi: 10.1002/ana.24056. Epub 2014 Apr 2. No abstract available.

PMID:
24242978
11.

Functional screening in Drosophila identifies Alzheimer's disease susceptibility genes and implicates Tau-mediated mechanisms.

Shulman JM, Imboywa S, Giagtzoglou N, Powers MP, Hu Y, Devenport D, Chipendo P, Chibnik LB, Diamond A, Perrimon N, Brown NH, De Jager PL, Feany MB.

Hum Mol Genet. 2014 Feb 15;23(4):870-7. doi: 10.1093/hmg/ddt478. Epub 2013 Sep 25.

12.

Clinical correlates in an experimental model of repetitive mild brain injury.

Mannix R, Meehan WP, Mandeville J, Grant PE, Gray T, Berglass J, Zhang J, Bryant J, Rezaie S, Chung JY, Peters NV, Lee C, Tien LW, Kaplan DL, Feany M, Whalen M.

Ann Neurol. 2013 Jul;74(1):65-75. doi: 10.1002/ana.23858. Epub 2013 Aug 6.

PMID:
23922306
13.

Why size matters - balancing mitochondrial dynamics in Alzheimer's disease.

DuBoff B, Feany M, Götz J.

Trends Neurosci. 2013 Jun;36(6):325-35. doi: 10.1016/j.tins.2013.03.002. Epub 2013 Apr 11. Review.

PMID:
23582339
14.

Tau promotes neurodegeneration via DRP1 mislocalization in vivo.

DuBoff B, Götz J, Feany MB.

Neuron. 2012 Aug 23;75(4):618-32. doi: 10.1016/j.neuron.2012.06.026.

15.

Mediators of a long-term movement abnormality in a Drosophila melanogaster model of classic galactosemia.

Ryan EL, DuBoff B, Feany MB, Fridovich-Keil JL.

Dis Model Mech. 2012 Nov;5(6):796-803. doi: 10.1242/dmm.009050. Epub 2012 Jun 26.

16.

Alexander disease.

Messing A, Brenner M, Feany MB, Nedergaard M, Goldman JE.

J Neurosci. 2012 Apr 11;32(15):5017-23. doi: 10.1523/JNEUROSCI.5384-11.2012. No abstract available.

17.

A neuroprotective role for the DNA damage checkpoint in tauopathy.

Khurana V, Merlo P, DuBoff B, Fulga TA, Sharp KA, Campbell SD, Götz J, Feany MB.

Aging Cell. 2012 Apr;11(2):360-2. doi: 10.1111/j.1474-9726.2011.00778.x. Epub 2012 Feb 1.

18.

Protein misfolding and oxidative stress promote glial-mediated neurodegeneration in an Alexander disease model.

Wang L, Colodner KJ, Feany MB.

J Neurosci. 2011 Feb 23;31(8):2868-77. doi: 10.1523/JNEUROSCI.3410-10.2011.

19.

Functional screening of Alzheimer pathology genome-wide association signals in Drosophila.

Shulman JM, Chipendo P, Chibnik LB, Aubin C, Tran D, Keenan BT, Kramer PL, Schneider JA, Bennett DA, Feany MB, De Jager PL.

Am J Hum Genet. 2011 Feb 11;88(2):232-8. doi: 10.1016/j.ajhg.2011.01.006. Epub 2011 Feb 3.

20.

Glial fibrillary tangles and JAK/STAT-mediated glial and neuronal cell death in a Drosophila model of glial tauopathy.

Colodner KJ, Feany MB.

J Neurosci. 2010 Dec 1;30(48):16102-13. doi: 10.1523/JNEUROSCI.2491-10.2010.

Supplemental Content

Loading ...
Support Center